NCT03670212 - Investigation of Nicotine Seeking Behavior in Current Smokers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 7, 2016

Primary Completion Date

October 4, 2016

Study Completion Date

October 4, 2016

Conditions

Cigarette Smoking

Interventions

DRUG

Yohimbine Hydrochloride

54mg of yohimbine powder was encapsulated in a generic opaque capsule and swallowed with water.

DRUG

Hydrocortisone

10mg hydrocortisone was encapsulated in a generic opaque capsule and swallowed with water.

DRUG

Lactose Monohydrate Powder

Lactose powder was encapsulated in generic opaque capsules identical to those used during the acute stress session. Lactose doses weighed the same as the acute stress session doses (54mg and 10mg, respectively).

Trial Locations (1)

48201

Wayne State University, Detroit

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Wayne State University

OTHER